Therapeutic regimens for chimeric antigen receptor (car)- expressing cells
US-2021177896-A1 · Jun 17, 2021 · US
This page is not indexed by search engines while we improve data quality.
Porter David L patents
Porter David L holds 5 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 5 |
| Recent patents | 0 |
| First publication | Mar 10, 2016 |
| Latest publication | Jun 17, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
US-2018140602-A1 · May 24, 2018 · US
Treatment of cancer using a CD123 chimeric antigen receptor
US-9815901-B2 · Nov 14, 2017 · US
Use of chimeric antigen receptor-modified T-cells to treat cancer
US-9499629-B2 · Nov 22, 2016 · US
Treatment of cancer using a cd123 chimeric antigen receptor
US-2016068601-A1 · Mar 10, 2016 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Therapeutic regimens for chimeric antigen receptor (car)- expressing cells
US-2021177896-A1 · Jun 17, 2021 · US
Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
US-2018140602-A1 · May 24, 2018 · US
Treatment of cancer using a CD123 chimeric antigen receptor
US-9815901-B2 · Nov 14, 2017 · US
Use of chimeric antigen receptor-modified T-cells to treat cancer
US-9499629-B2 · Nov 22, 2016 · US
Treatment of cancer using a cd123 chimeric antigen receptor
US-2016068601-A1 · Mar 10, 2016 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 5 |
| A61K40/4211 | 5 |
| A61K40/31 | 5 |
| A61K40/11 | 5 |
| A61K2239/48 | 5 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 5 |
| Chemistry & Metallurgy | 5 |
| Physics | 1 |